BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33450747)

  • 1. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies.
    Zhang BM; Keegan A; Li P; Lindeman NI; Nagarajan R; Routbort MJ; Vasalos P; Kim AS; Merker JD
    Arch Pathol Lab Med; 2021 Sep; 145(9):1110-1116. PubMed ID: 33450747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
    Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
    Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Sequencing Somatic and Germline Assay Troubleshooting Guide Derived From Proficiency Testing Data.
    Nardi V; Tsuchiya KD; Kim AS; Bean LJH; Halley JG; Long TA; Szelinger S; Vasalos P; Thorson JA; Moyer AM; Moncur JT
    Arch Pathol Lab Med; 2022 Apr; 146(4):451-461. PubMed ID: 34424952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiered Somatic Variant Classification Adoption Has Increased Worldwide With Some Practice Differences Based on Location and Institutional Setting.
    Bruehl FK; Kim AS; Li MM; Lindeman NI; Moncur JT; Souers RJ; Vasalos P; Voelkerding KV; Xian RR; Surrey LF
    Arch Pathol Lab Med; 2022 Jul; 146(7):822-832. PubMed ID: 34979564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.
    Devereaux KA; Souers RJ; Merker JD; Lindeman NI; Graham RP; Hameed MR; Vasalos P; Moncur JT; Lockwood CM; Xian RR
    Arch Pathol Lab Med; 2023 Apr; 147(4):425-433. PubMed ID: 35687785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
    Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
    Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on
    Surrey LF; Oakley FD; Merker JD; Long TA; Vasalos P; Moncur JT; Kim AS
    Arch Pathol Lab Med; 2019 Aug; 143(8):980-984. PubMed ID: 30865489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing.
    Duncavage EJ; Abel HJ; Merker JD; Bodner JB; Zhao Q; Voelkerding KV; Pfeifer JD
    Arch Pathol Lab Med; 2016 Oct; 140(10):1085-91. PubMed ID: 27388684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the
    Moncur JT; Bartley AN; Bridge JA; Kamel-Reid S; Lazar AJ; Lindeman NI; Long TA; Merker JD; Rai AJ; Rimm DL; Rothberg PG; Vasalos P; Kim AS
    Arch Pathol Lab Med; 2019 Oct; 143(10):1203-1211. PubMed ID: 30969158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
    Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
    Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot study.
    Spence T; Stickle N; Yu C; Chow H; Feilotter H; Lo B; McCready E; Sadikovic B; Siu LL; Bedard PL; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):e717-e732. PubMed ID: 31896942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of next-generation sequencing in hematologic malignancies.
    Ramkissoon LA; Montgomery ND
    Hum Immunol; 2021 Nov; 82(11):859-870. PubMed ID: 33648805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying potential germline variants from sequencing hematopoietic malignancies.
    Kraft IL; Godley LA
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):219-227. PubMed ID: 33275754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying potential germline variants from sequencing hematopoietic malignancies.
    Kraft IL; Godley LA
    Blood; 2020 Nov; 136(22):2498-2506. PubMed ID: 33236764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-Year Laboratory Performance of the First College of American Pathologists In Silico Next-Generation Sequencing Bioinformatics Proficiency Testing Surveys.
    Furtado LV; Souers RJ; Vasalos P; Halley JG; Aisner DL; Nagarajan R; Voelkerding KV; Merker JD; Konnick EQ
    Arch Pathol Lab Med; 2023 Feb; 147(2):137-142. PubMed ID: 35671151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
    He J; Abdel-Wahab O; Nahas MK; Wang K; Rampal RK; Intlekofer AM; Patel J; Krivstov A; Frampton GM; Young LE; Zhong S; Bailey M; White JR; Roels S; Deffenbaugh J; Fichtenholtz A; Brennan T; Rosenzweig M; Pelak K; Knapp KM; Brennan KW; Donahue AL; Young G; Garcia L; Beckstrom ST; Zhao M; White E; Banning V; Buell J; Iwanik K; Ross JS; Morosini D; Younes A; Hanash AM; Paietta E; Roberts K; Mullighan C; Dogan A; Armstrong SA; Mughal T; Vergilio JA; Labrecque E; Erlich R; Vietz C; Yelensky R; Stephens PJ; Miller VA; van den Brink MR; Otto GA; Lipson D; Levine RL
    Blood; 2016 Jun; 127(24):3004-14. PubMed ID: 26966091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.
    Zhong Q; Wagner U; Kurt H; Molinari F; Cathomas G; Komminoth P; Barman-Aksözen J; Schneider-Yin X; Rey JP; Vassella E; Rogel U; Diebold J; McKee T; Jochum W; Kashofer K; Hofman P; Zischka M; Moch H; Rechsteiner M; Wild PJ
    Pathol Res Pract; 2018 Jul; 214(7):957-963. PubMed ID: 29807778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.
    Merker JD; Devereaux K; Iafrate AJ; Kamel-Reid S; Kim AS; Moncur JT; Montgomery SB; Nagarajan R; Portier BP; Routbort MJ; Smail C; Surrey LF; Vasalos P; Lazar AJ; Lindeman NI
    Arch Pathol Lab Med; 2019 Apr; 143(4):463-471. PubMed ID: 30376374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.